相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A roadmap to increase diversity in genomic studies
Segun Fatumo et al.
NATURE MEDICINE (2022)
Limited evolution of the actionable metastatic cancer genome under therapeutic pressure
Joris van de Haar et al.
NATURE MEDICINE (2021)
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
A. Rose Brannon et al.
NATURE COMMUNICATIONS (2021)
From Tissue-Agnostic to N-of-One Therapies:(R)Evolution of the Precision Paradigm
Jacob J. Adashek et al.
TRENDS IN CANCER (2021)
Enabling Precision Oncology Through Precision Diagnostics
Noah A. Brown et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020 (2020)
Molecular profiling for precision cancer therapies
Eoghan R. Malone et al.
GENOME MEDICINE (2020)
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
Ciska Verbaanderd et al.
FRONTIERS IN PHARMACOLOGY (2020)
Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study.
Adam Gondos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
Eric Faulkner et al.
VALUE IN HEALTH (2020)
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions
Patricia A. Deverka et al.
VALUE IN HEALTH (2020)
Impact and Diagnostic Gaps of Comprehensive Genomic Profiling in Real-World Clinical Practice
Aditi P. Singh et al.
CANCERS (2020)
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'
Benedikt C. Westphalen et al.
EUROPEAN JOURNAL OF CANCER (2020)
Lung cancer biomarker testing: perspective from Europe
Erik Thunnissen et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal
David Tamborero et al.
NATURE MEDICINE (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
Bruce A. Feinberg et al.
VALUE IN HEALTH (2020)
Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy
Shumei Kato et al.
NATURE COMMUNICATIONS (2020)
A Systematic Review of the Value Assessment Frameworks Used within Health Technology Assessment of Omics Technologies and Their Actual Adoption from HTA Agencies
Ilda Hoxhaj et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
F. Mosele et al.
ANNALS OF ONCOLOGY (2020)
Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
R. Condorelli et al.
ANNALS OF ONCOLOGY (2019)
New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology
Perrine Janiaud et al.
CANCER TREATMENT REVIEWS (2019)
Real-world data: towards achieving the achievable in cancer care
Christopher M. Booth et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer
Natasha B. Leighl et al.
CLINICAL CANCER RESEARCH (2019)
Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
Alison Cave et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
A systematic analysis of off-label drug use in real-world data (RWD) across more than 145,000 cancer patients.
Jonathan McCafferty et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
Jason K. Sicklick et al.
NATURE MEDICINE (2019)
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs
D. L. van der Velden et al.
NATURE (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
Prospective analysis of 895 patients on a UK Genomics Review Board
David Allan Moore et al.
ESMO OPEN (2019)
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients
Michael J. Pishvaian et al.
JAMIA OPEN (2019)
The evidence framework for precision cancer medicine
Jeffrey A. Moscow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness
O. Tan et al.
CLINICAL GENETICS (2018)
PEER-REVIEWED JOURNAL EDITORS' VIEWS ON REAL-WORLD EVIDENCE
Elisabeth M. Oehrlein et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2018)
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J. Mateo et al.
ANNALS OF ONCOLOGY (2018)
Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting
Carolyn J. Presley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers
Subotheni Thavaneswaran et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L. R. Yates et al.
ANNALS OF ONCOLOGY (2018)
Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Rick Kamps et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing
Masayuki Nagahashi et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Molecular Tumor Boards: current practice and future needs
D. L. van der Velden et al.
ANNALS OF ONCOLOGY (2017)
A classification system for clinical relevance of somatic variants identified in molecular profiling of cancer
Mahadeo A. Sukhai et al.
GENETICS IN MEDICINE (2016)
Facilitating a culture of responsible and effective sharing of cancer genome data
Lillian L. Siu et al.
NATURE MEDICINE (2016)
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
Christian Dittrich et al.
ESMO OPEN (2016)
Patient-reported outcomes for patients undergoing radical cystectomy: a prospective case-control study
Catharina A. Goossens-Laan et al.
SUPPORTIVE CARE IN CANCER (2014)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes
Jennifer J. Johnston et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
分享论文
